Literature DB >> 9685702

Mutagenesis induced by the tumor microenvironment.

J Yuan1, P M Glazer.   

Abstract

Genomic instability is a commonly observed feature of tumors. Most investigations addressing the mechanism of tumor progression have focused on the genetic factors that may play a role. Growing evidence now suggests that, in addition to these endogenous factors, the exogenous environment within solid tumors may by itself be mutagenic and constitute a significant source of genetic instability. The tumor microenvironment is characterized by regions of fluctuating hypoxia, low pH, and nutrient deprivation. Each of these microenvironmental factors has been shown to cause severe disturbance in cell metabolism and physiology. Both in vivo and in vitro data demonstrate that exposure of tumor cells to adverse conditions can directly cause mutations, contributing to genetic instability. In this review, we will reexamine the current body of evidence on the role of the tumor microenvironment in inducing mutagenesis and consequent tumor progression. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Year:  1998        PMID: 9685702     DOI: 10.1016/s0027-5107(98)00042-6

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  34 in total

1.  Silencing of the DNA mismatch repair gene MLH1 induced by hypoxic stress in a pathway dependent on the histone demethylase LSD1.

Authors:  Yuhong Lu; Narendra Wajapeyee; Mitchell S Turker; Peter M Glazer
Journal:  Cell Rep       Date:  2014-07-17       Impact factor: 9.423

Review 2.  Complex interplay between tumor microenvironment and cancer therapy.

Authors:  Minhong Shen; Yibin Kang
Journal:  Front Med       Date:  2018-08-10       Impact factor: 4.592

3.  Glucose deprivation is associated with Chk1 degradation through the ubiquitin-proteasome pathway and effective checkpoint response to replication blocks.

Authors:  Ae Jeong Kim; Hyun-Ju Kim; Hye Jin Jee; Naree Song; Minjee Kim; Yoe-Sik Bae; Jay H Chung; Jeanho Yun
Journal:  Biochim Biophys Acta       Date:  2011-04-01

4.  Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.

Authors:  Shoko Nakasone; Sachiyo Mimaki; Tomohiro Ichikawa; Keiju Aokage; Tomohiro Miyoshi; Masato Sugano; Motohiro Kojima; Satoshi Fujii; Takeshi Kuwata; Atsushi Ochiai; Masahiro Tsuboi; Koichi Goto; Katsuya Tsuchihara; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-06       Impact factor: 4.553

Review 5.  The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.

Authors:  Larry H Matherly; Zhanjun Hou; Aleem Gangjee
Journal:  Cancer Chemother Pharmacol       Date:  2017-11-10       Impact factor: 3.333

Review 6.  Impact of hypoxia on DNA repair and genome integrity.

Authors:  Alanna R Kaplan; Peter M Glazer
Journal:  Mutagenesis       Date:  2020-02-13       Impact factor: 3.000

Review 7.  The emerging roles of exosomes in tumor-stroma interaction.

Authors:  Hailong Fu; Huan Yang; Xu Zhang; Wenrong Xu
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-17       Impact factor: 4.553

Review 8.  Hypoxia-induced genetic instability--a calculated mechanism underlying tumor progression.

Authors:  L Eric Huang; Ranjit S Bindra; Peter M Glazer; Adrian L Harris
Journal:  J Mol Med (Berl)       Date:  2006-12-20       Impact factor: 4.599

9.  Modification of cysteine 457 in plakoglobin modulates the proliferation and migration of colorectal cancer cells by altering binding to E-cadherin/catenins.

Authors:  Suhee Kim; Sun Hee Ahn; Hee-Young Yang; Jin-Sil Lee; Hyang-Gi Choi; Young-Kyu Park; Tae-Hoon Lee
Journal:  Redox Rep       Date:  2016-08-29       Impact factor: 4.412

10.  MicroRNA regulation of DNA repair gene expression in hypoxic stress.

Authors:  Meredith E Crosby; Ritu Kulshreshtha; Mircea Ivan; Peter M Glazer
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.